Our participating companies

Pharma in silica’s precision chemotherapy attacks solid tumors while sparing patients painful, maiming and costly adverse effects imposed by current chemo. OpPacli™ is fifteen months to FDA Phase I...

QuantaPro enables oncologists to determine—early and in real time—whether chemotherapy will work, using a single drop of blood. Beginning with the ERCC1 chemo-resistance test, the company addr...

KizaVie™ (LEAF-4L6715) is a late-stage, first-in-class therapeutic platform designed to restore oxygen diffusion at the microvascular level—addressing a fundamental physi...

Pilot scale production of Omega Power Safe™ fireproof batteries will lead to a fast-track to revenue with their U.S. based manufacturing partnerships. Follow on Series A funding of $25M will lead ...